166 related articles for article (PubMed ID: 3861793)
1. Pharmacokinetics of an indium-111-labeled monoclonal antibody in cancer patients.
Hnatowich DJ; Griffin TW; Kosciuczyk C; Rusckowski M; Childs RL; Mattis JA; Shealy D; Doherty PW
J Nucl Med; 1985 Aug; 26(8):849-58. PubMed ID: 3861793
[TBL] [Abstract][Full Text] [Related]
2. Antibody guided targeting of non-small cell lung cancer using 111In-labeled HMFG1 F(ab')2 fragments.
Kalofonos HP; Sivolapenko GB; Courtenay-Luck NS; Snook DE; Hooker GR; Winter R; McKenzie CG; Taylor-Papadimitriou JJ; Lavender PJ; Epenetos AA
Cancer Res; 1988 Apr; 48(7):1977-84. PubMed ID: 2832056
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of 111In-labeled OC-125 antibody in cancer patients compared with the 19-9 antibody.
Hnatowich DJ; Gionet M; Rusckowski M; Siebecker DA; Roche J; Shealy D; Mattis JA; Wilson J; McGann J; Hunter RE
Cancer Res; 1987 Nov; 47(22):6111-7. PubMed ID: 3664510
[TBL] [Abstract][Full Text] [Related]
4. Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response.
Le Doussal JM; Chetanneau A; Gruaz-Guyon A; Martin M; Gautherot E; Lehur PA; Chatal JF; Delaage M; Barbet J
J Nucl Med; 1993 Oct; 34(10):1662-71. PubMed ID: 8410279
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics in patients of an anti-carcinoembryonic antigen antibody radiolabeled with indium-111 using a novel diethylenetriamine pentaacetic acid chelator.
Hnatowich DJ; Rusckowski M; Brill AB; Siebecker DA; Misra H; Mardirossian G; Bushe H; Rescigno A; Stevens S; Johnson DK
Cancer Res; 1990 Nov; 50(22):7272-8. PubMed ID: 2224858
[TBL] [Abstract][Full Text] [Related]
6. Tumor targeting properties of indium-111 labeled genetically engineered Fab' and F(ab')2 constructs of chimeric tumor necrosis treatment (chTNT)-3 antibody.
Khawli LA; Alauddin MM; Hu P; Epstein AL
Cancer Biother Radiopharm; 2003 Dec; 18(6):931-40. PubMed ID: 14969605
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of tumor targeting with the anticarcinoembryonic antigen murine monoclonal antibody fragment, MN-14 F(ab)2.
Juweid M; Sharkey RM; Behr TM; Swayne LC; Dunn R; Ying Z; Siegel JA; Hansen HJ; Goldenberg DM
Cancer; 1996 Jul; 78(1):157-68. PubMed ID: 8646712
[TBL] [Abstract][Full Text] [Related]
8. Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice.
Le Doussal JM; Gruaz-Guyon A; Martin M; Gautherot E; Delaage M; Barbet J
Cancer Res; 1990 Jun; 50(11):3445-52. PubMed ID: 2334941
[TBL] [Abstract][Full Text] [Related]
9. Regional and systemic distribution of anti-tumor x anti-CD3 heteroaggregate antibodies and cultured human peripheral blood lymphocytes in a human colon cancer xenograft.
Nelson H; Ramsey PS; Kerr LA; McKean DJ; Donohue JH
J Immunol; 1990 Nov; 145(10):3507-15. PubMed ID: 1700013
[TBL] [Abstract][Full Text] [Related]
10. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution of indium-111-labeled OC 125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomas.
Chatal JF; Saccavini JC; Gestin JF; Thédrez P; Curtet C; Kremer M; Guerreau D; Nolibé D; Fumoleau P; Guillard Y
Cancer Res; 1989 Jun; 49(11):3087-94. PubMed ID: 2720667
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic mice.
Massuger LF; Boerman OC; Corstens FH; Verheijen RH; Claessens RA; Poels LG; van den Broek WJ; Kenemans P
Anticancer Res; 1991; 11(6):2051-7. PubMed ID: 1776839
[TBL] [Abstract][Full Text] [Related]
13. Tumor location using F(ab')2 mu from a monoclonal IgM antibody: pharmacokinetics.
Ballou B; Reiland J; Levine G; Knowles B; Hakala TR
J Nucl Med; 1985 Mar; 26(3):283-92. PubMed ID: 2857779
[TBL] [Abstract][Full Text] [Related]
14. Localization of human osteogenic sarcoma xenografts in nude mice by a monoclonal antibody labeled with radioiodine and indium-111.
Sakahara H; Endo K; Nakashima T; Koizumi M; Kunimatsu M; Kawamura Y; Ohta H; Nakamura T; Tanaka H; Kotoura Y
J Nucl Med; 1987 Mar; 28(3):342-8. PubMed ID: 3469333
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model.
Tahtis K; Lee FT; Smyth FE; Power BE; Renner C; Brechbiel MW; Old LJ; Hudson PJ; Scott AM
Clin Cancer Res; 2001 Apr; 7(4):1061-72. PubMed ID: 11309358
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactivity and biodistribution of indium-111-labeled monoclonal antibody to a human high molecular weight-melanoma associated antigen.
Fawwaz RA; Wang TS; Estabrook A; Rosen JM; Hardy MA; Alderson PO; Srivastava SC; Richards P; Ferrone S
J Nucl Med; 1985 May; 26(5):488-92. PubMed ID: 3989605
[TBL] [Abstract][Full Text] [Related]
17. Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody.
Lamki LM; Patt YZ; Rosenblum MG; Shanken LJ; Thompson LB; Schweighardt SA; Frincke JM; Murray JL
Radiology; 1990 Jan; 174(1):147-51. PubMed ID: 2294542
[TBL] [Abstract][Full Text] [Related]
18. The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody.
Davidson BR; Babich J; Young H; Waddington W; Clarke G; Short M; Boulos P; Styles J; Dean C
Br J Cancer; 1991 Nov; 64(5):850-6. PubMed ID: 1931605
[TBL] [Abstract][Full Text] [Related]
19. Effect of conjugation on the biodistribution of 111In-labelled anti-PAP and anti-PSA monoclonal antibodies examined in nude mice with PC-82 human tumor xenografts.
Perälä-Heape M; Vihko P; Pelkonen I; Laine A; Vihko R
In Vivo; 1991; 5(2):159-65. PubMed ID: 1722716
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of the monoclonal antibody B72.3 and its fragments labeled with either 125I or 111In.
Brown BA; Comeau RD; Jones PL; Liberatore FA; Neacy WP; Sands H; Gallagher BM
Cancer Res; 1987 Feb; 47(4):1149-54. PubMed ID: 3802096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
